Correction to British American Tobacco Article and Headlines
July 27 2017 - 1:33PM
Dow Jones News
BAT plans to make a "substantial equivalence" claim with the
Food and Drug Administration using Reynolds' product Eclipse. An
earlier version of the article incorrectly said in the second graph
that it was using another Reynold's product, Revo, in the claim.
British American Tobacco PLC doesn't sell its Glo
cigarette-alternative device in Italy. In the sixth graph, Chief
Executive Nicandro Durante incorrectly said it does. "BAT Will
Submit FDA Application Next Year to Sell Glo in US," at 6:43
ET.
The error also appeared in two headlines at 6:07 and 6:08
ET.
(END) Dow Jones Newswires
July 27, 2017 13:18 ET (17:18 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
British American Tobacco (NYSE:BTI)
Historical Stock Chart
From Aug 2024 to Sep 2024
British American Tobacco (NYSE:BTI)
Historical Stock Chart
From Sep 2023 to Sep 2024